Karyopharm Therapeutics Inc. buy Barclays PLC
Start price
13.05.25
/
50%
€0.54
Target price
13.05.26
€9.00
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 13.05.26. The prediction end date can be changed by Barclays_PLC at any time.Performance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Karyopharm Therapeutics Inc. | - | - |
| iShares Core DAX® | -1.553% | -0.123% |
| iShares Nasdaq 100 | -0.386% | -0.595% |
| iShares Nikkei 225® | 1.640% | 5.468% |
| iShares S&P 500 | 0.114% | -0.217% |
Comments by Barclays_PLC for this prediction
In the thread Karyopharm Therapeutics Inc. diskutieren
Karyopharm Therapeutics Inc. (NASDAQ: KPTI) had its price target raised by analysts at Barclays PLC from $5.00 to $10.00. They now have an "overweight" rating on the stock.
Ratings data for KPTI provided by MarketBeat